F6L-10068-97557
5 vaccinations
11 coded responses
47 check-ins
11 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 441 / OH
- Registered
- 2021-03-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-06
Registered in v-safe
-
2021-03-06
Dose 1 — Moderna
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-20
- 2021-03-27
-
2021-04-03
Dose 2 — Moderna
- 2021-04-03
-
2021-04-04
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea, Upper-airway cough syndrome — Feeling: Fair · Site: PainFree text: Runny nose and post nasal drip for 3-4 hrs last evening. Not experiencing nowMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-05
Survey response — days 1–6 daily, dose 2MedDRA: Pain in extremity — Feeling: Good · Site: PainFree text: 4/4 sore arm when reaching up. Upon waking up 4/5 soreness almost greatly reducedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-10
- 2021-04-17
-
2021-04-24
Survey response — day 21, dose 2MedDRA: Fatigue, Pre-existing disease — Feeling: FairFree text: Fatigue during swim work out more than normalMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-01
-
2021-05-08
Survey response — day 35, dose 2MedDRA: Fatigue — Feeling: FairFree text: Fatigue lasting into 5th week after 2nd dose. Only into 3rd week after 1st doseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-15
- 2021-07-03
- 2021-10-02
-
2021-11-05
Dose 3 — Moderna
-
2021-11-05
Survey response — day 0, dose 3MedDRA: No adverse event — Feeling: Good · Site: PainFree text: noneMedDRA releases: 2024-11 · check-in free text available
-
2021-11-06
Survey response — days 1–6 daily, dose 3MedDRA: Fatigue — Feeling: Good · Site: Pain, SwellingFree text: A small amount of fatigueMedDRA releases: 2024-11 · check-in free text available
-
2021-11-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Itching · Fatigue or tirednessAdult check-in
- 2021-11-08
-
2021-11-09
Survey response — days 1–6 daily, dose 3MedDRA: Fatigue — Feeling: Fair · Site: Pain, SwellingFree text: Fatigue more than normal during exerciseMedDRA releases: 2024-11 · check-in free text available
-
2021-11-11
Survey response — days 1–6 daily, dose 3MedDRA: Fatigue — Feeling: Good · Site: Swelling · Fatigue or tirednessFree text: Fatigue is significantly betterMedDRA releases: 2024-11 · check-in free text available
-
2021-11-12
Survey response — day 7, dose 3MedDRA: Fatigue — Feeling: Good · Site: Itching · Fatigue or tirednessFree text: Fatigue reduced moreMedDRA releases: 2024-11 · check-in free text available
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
-
2022-02-04
Survey response — 3 months, dose 3MedDRA: Exercise tolerance decreased, Fatigue, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Ease of fatigue especially swimming · Healthcare visit (other): Primary DocMedDRA releases: 2024-11 · check-in free text available
-
2022-02-04
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-03-31
-
2022-05-07
Survey response — 6 months, dose 3MedDRA: Arrhythmia, COVID-19 — Feeling: Good · Be unable to do your normal daily activitiesFree text: Heart arrhythmia on meds. Contracted COVID-19. Very mild symptoms. Paxlovid 5 day protocolMedDRA releases: 2024-11 · check-in free text available
-
2022-08-23
Dose 4 — Moderna
- 2022-11-05
-
2022-12-15
Dose 5 — Moderna
- 2022-12-22
- 2022-12-29
- 2023-01-05
- 2023-01-12
- 2023-01-19
- 2023-01-26
- 2023-03-16
- 2023-06-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-06 | Moderna | |
| 2 | 2021-04-03 | Moderna | |
| 3 | 2021-11-05 | Moderna | No |
| 4 | 2022-08-23 | Moderna | No |
| 5 | 2022-12-15 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Runny nose and post nasal drip for 3-4 hrs last evening. Not experiencing now
Systemic reaction (other): 4/4 sore arm when reaching up. Upon waking up 4/5 soreness almost greatly reduced
Release 7 — day 21, dose 2
Symptoms: Fatigue during swim work out more than normal
Release 8 — day 35, dose 2
Symptoms: Fatigue lasting into 5th week after 2nd dose. Only into 3rd week after 1st dose
Release 10 — day 0, dose 3
Systemic reaction (other): none
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): A small amount of fatigue
Systemic reaction (other): Fatigue more than normal during exercise
Systemic reaction (other): Fatigue is significantly better
Release 10 — day 7, dose 3
Systemic reaction (other): Fatigue reduced more
Release 11 — 3 months, dose 3
Release 11 — 6 months, dose 3
Symptoms: Heart arrhythmia on meds. Contracted COVID-19. Very mild symptoms. Paxlovid 5 day protocol
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Arrhythmia | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Exercise tolerance decreased | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release